Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation

Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation

US Patent 8497349 · Granted Jul 30, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion peptides as antimicrobial agents2024
Peptide-oligourea hybrid compounds2022
Peptide-oligourea foldamer compounds and methods of their use2022
Pro-drug peptide with improved pharmaceutical properties2021
Bioinspired catalysis using oligourea helical foldamers2019
Peptide-oligourea chimeric compounds and methods of their use2019
Foldamer helix bundle-based molecular encapsulation2019
Methods of treating chronic inflammatory diseases2019
Modified peptides and their use for treating autoimmune diseases2017
Compositions comprising multivalent synthetic ligands of surface nucleolin and g2016
Use of multivalent synthetic ligands of surface nucleolin for treating cancer or2016
Use of multivalent synthetic ligands of surface nucleolin for treating cancer or2016